Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NOVAVAX INC Director's Dealing 2017

Feb 2, 2017

31982_dirs_2017-02-02_c8b7d512-83f1-45fd-8e6c-e62b569f3987.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2017-01-31

Reporting Person: Trizzino John (SVP, Commercial Operations)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-01-31 Common Stock P 3401 $1.12 Acquired 88965 Direct

Footnotes

F1: Includes 3,401 shares acquired under the Issuer's Amended and Restated 2013 Employee Stock Purchase Plan on January 31, 2017.